The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The literature evidence used here is consistent with the zebrafish (Danio rerio) gene gtpbp3 encoding a mitochondrial TrmE-type GTPase also described as a mitochondrial tRNA taurine-modification enzyme (GTP-binding protein 3, mitochondrial). Mechanistic sources describe a mitochondrial targeting sequence and a TrmE-type (MnmE-like) G domain required for GTP binding/hydrolysis, matching the UniProt Q501Z5 description and domain expectations. This report excludes unrelated similarly named proteins (e.g., gtpbp1l) and focuses on the mitochondrial tRNA-modification GTPBP3 axis. (zhang2023pathogenicityanalysisof pages 13-15, zhang2023pathogenicityanalysisof pages 1-2)
A central concept for annotating gtpbp3 is that specific mitochondrial tRNAs carry wobble-position (U34) modifications that improve decoding and translation fidelity/efficiency of mitochondrial mRNAs. In this framework, GTPBP3 is placed in the enzyme system that generates 5-taurinomethyluridine (τm5U) and/or its thiolated derivative τm5(s2)U at U34 in subsets of mitochondrial tRNAs. Loss of these modifications is widely considered a causal mechanism for impaired mitochondrial translation and downstream oxidative phosphorylation (OXPHOS) dysfunction. (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12)
GTPBP3 is described as a nuclear-encoded mitochondrial tRNA-modifying enzyme with an atypical TrmE-type GTPase domain where GTP hydrolysis is functionally important for its role in tRNA modification. Domain architecture reported in a 2023 systematic review includes an N-terminal mitochondrial targeting region and multiple structural segments, including a G (TrmE-type) domain containing conserved motifs (G1–G5 and switch regions) supporting guanine nucleotide/Mg2+ binding and GTPase function. (zhang2023pathogenicityanalysisof pages 13-15, zhang2023pathogenicityanalysisof pages 1-2)
Across mechanistic summaries, GTPBP3 functions together with MTO1 in the biosynthesis of τm5U/τm5(s2)U at mitochondrial tRNA wobble uridine (U34). This is the most specific and best-supported molecular function available in the retrieved evidence. (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12, xie2024expandingthephenotypic pages 1-2)
Mechanistic descriptions of the GTPBP3–MTO1 system state that formation of τm5U involves:
- Substrates: taurine and 5,10-methylenetetrahydrofolate (5,10-CH2-THF) (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12)
- Cofactors/requirements: GTP, K+, and FAD (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12)
- Metabolic provisioning: upstream one-carbon units can be provided by SHMT2 or the glycine-cleavage pathway (zhang2023pathogenicityanalysisof pages 1-2)
Under taurine starvation, a reviewed mechanism indicates the complex can use glycine to generate cmnm5U (a bacterial-like alternative) rather than τm5U, highlighting metabolic context dependence of the chemistry. (magistrati2023modopathiescausedby pages 11-12)
The 2023 mechanistic summary associates this modification system with selected mt-tRNAs that require taurine-dependent wobble modifications; the zebrafish Mto1 study discusses sets including mt-tRNA[Glu, Gln, Lys, Trp, Leu(UUR)] in the context of taurine modification biology, and cross-references biochemical similarities to gtpbp3KO fish. (zhang2023pathogenicityanalysisof pages 1-2, zhang2021ablationofmto1 pages 11-12)
Multiple sources converge that GTPBP3 acts as part of a functional complex with MTO1 in mitochondrial tRNA wobble modification. A 2023 analysis describes a physical/functional complex where GTPBP3 dimerizes via the N-terminus and interacts with MTO1 via a central helical region to form a higher-order complex supporting the modification reaction. (zhang2023pathogenicityanalysisof pages 1-2)
Reviews of “mitochondrial RNA modopathies” place GTPBP3 within a broader network of mt-tRNA modification enzymes, including those involved in thiolation (e.g., TRMU/MTU1) that can act downstream/parallel to τm5U formation (noting that τm5(s2)U includes a thiolation component). (magistrati2023modopathiescausedby pages 11-12)
GTPBP3 is consistently described as mitochondrial (including presence of a mitochondrial targeting sequence and its placement in mitochondrial tRNA modification machinery). This supports annotating the zebrafish protein as a mitochondrial matrix-facing enzyme involved in mt-tRNA maturation/decoding (precise submitochondrial compartment was not directly measured in the retrieved text). (杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5, zhang2023pathogenicityanalysisof pages 13-15, zhang2023pathogenicityanalysisof pages 1-2)
Direct zebrafish evidence available in the retrieved texts indicates that deletion of gtpbp3 in zebrafish causes hypertrophic cardiomyopathy, and that this phenotype is associated with aberrant mitochondrial tRNA metabolism. (zhang2023pathogenicityanalysisof pages 15-15)
A 2024 Chinese-language review also cites zebrafish work reporting that defective expression of gtpbp3 (in the context of tRNA modification) alters mitochondrial function and zebrafish development, consistent with mitochondrial dysfunction affecting high-energy tissues during development. (杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5)
The zebrafish Mto1 knockout paper (focused on Mto1) cross-references gtpbp3 knockout findings and notes that gtpbp3KO zebrafish showed increased efficiencies of tRNA aminoacylation, and that mt-tRNA instability signatures discussed for Mto1 deficiency were reported as similar to those in gtpbp3-related models. However, detailed numeric measures (e.g., OXPHOS complex activities, heart function metrics) for gtpbp3KO specifically were not present in the retrieved excerpts and appear to reside in the primary zebrafish gtpbp3 papers that were not fully obtainable in this run. (zhang2021ablationofmto1 pages 11-12)
Implication for annotation: despite limited direct zebrafish biochemical detail in the retrieved text, the phenotype (cardiomyopathy) + aberrant mitochondrial tRNA metabolism strongly supports conserving the canonical mitochondrial tRNA wobble-modification function for zebrafish Gtpbp3. (zhang2023pathogenicityanalysisof pages 15-15, zhang2021ablationofmto1 pages 11-12)
A 2023 study and systematic review consolidated the mechanism that the GTPBP3–MTO1 complex mediates taurine modifications (τm5U/τm5s2U) at U34 using taurine and 5,10-CH2-THF and requiring GTP/K+/FAD, and it curated clinical cases for COXPD23, enabling quantitative genotype–phenotype patterns (see Statistics section). (Publication date: Feb 2023; URL: https://doi.org/10.3390/genes14030552). (zhang2023pathogenicityanalysisof pages 1-2)
A 2023 review on mitochondrial RNA modifying enzyme “modopathies” emphasized (i) the substrate/cofactor requirements and (ii) that under taurine starvation the system can shift to glycine-dependent chemistry (cmnm5U), framing a metabolic contingency that may influence phenotype and potentially therapeutic strategies. (Publication date: Jan 2023; URL: https://doi.org/10.3390/ijms24032178). (magistrati2023modopathiescausedby pages 11-12)
A 2024 Orphanet Journal of Rare Diseases paper reported 13 GTPBP3-associated variants in 9 Chinese pedigrees, including 8 novel variants, and used patient-derived immortalized lymphocytes and cell models plus re-expression of variants in knockout cell lines to support pathogenicity and to link variants to impaired mitochondrial energetic biogenesis. (Publication date: Dec 2024; URL: https://doi.org/10.1186/s13023-024-03469-3). (xie2024expandingthephenotypic pages 1-2, xie2024expandingthephenotypic pages 3-4)
Also in 2024, a Chinese review article specifically focused on GTPBP3 mutations and cardiomyopathy, summarizing clinical observations and integrating pathway concepts around GTPBP3/MTO1 and mitochondrial dysfunction (Publication year: 2024; URL: https://doi.org/10.12125/j.chj.202212029). (杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5)
Recent studies highlight real-world clinical implementation via:
- Whole-exome sequencing (WES) to identify candidate GTPBP3 variants in suspected mitochondrial disease (xie2024expandingthephenotypic pages 1-2)
- Patient-derived cell assays demonstrating reduced GTPBP3 levels and impaired mitochondrial energetic biogenesis, supporting variant interpretation and clinical classification (xie2024expandingthephenotypic pages 1-2, xie2024expandingthephenotypic pages 3-4)
- Variant re-expression in knockout cell lines to define pathogenicity of novel alleles (xie2024expandingthephenotypic pages 1-2)
Expert review framing describes GTPBP3 deficiency as a mitochondrial “modopathy” where loss or reduction of a specific mt-tRNA modification impairs mitochondrial translation and leads to tissue phenotypes (notably cardiac and neurological). The 2023 modopathy review summarizes reported patient presentations and highlights the need for model systems to validate novel/private mutations due to rarity and heterogeneity. (magistrati2023modopathiescausedby pages 11-12)
A 2023 systematic review of GTPBP3 variants argues that the TrmE-type G domain is crucial for function (variant enrichment in this domain) and that loss-of-function mechanisms are common among severe presentations, supporting the concept that disrupted GTPase-driven tRNA modification is a primary molecular lesion rather than a secondary effect. (zhang2023pathogenicityanalysisof pages 1-2)
From the 2023 systematic review/case report:
- 18 COXPD23 patients curated (zhang2023pathogenicityanalysisof pages 1-2)
- Average onset age: 1.7 years; 3 months for a reported homozygote (zhang2023pathogenicityanalysisof pages 1-2)
- Variant class enrichment: Loss-of-function variants 48.6% in patients vs 8.9% in gnomAD (p < 0.0001); 31% frameshift (zhang2023pathogenicityanalysisof pages 1-2)
- Genotype–severity association: severe cases had 71.4% homozygous vs 18.1% compound heterozygous (zhang2023pathogenicityanalysisof pages 1-2)
From Xie et al. 2024:
- 13 variants across 9 pedigrees, with 8 novel (xie2024expandingthephenotypic pages 1-2, xie2024expandingthephenotypic pages 3-4)
- Reported quantitative clinical values in examples include blood lactate 26 mM, 9.18 mM, 6.94 mmol/L, 8.3 mM, and cardiac function metrics such as EF 38% and NT-proBNP 894 pg/mL (xie2024expandingthephenotypic pages 3-4)
- Reported hotspot in this cohort: c.689A>C, and clustering in exons 4 and 6 (xie2024expandingthephenotypic pages 1-2)
The 2024 review reports a pediatric case with cardiomyopathy including LVEF 27% and lactate 3.2 mmol/L, with noted clinical improvement after therapy and 6-year follow-up (as summarized in the review). (杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5)
| Category | Key details | Key citations |
|---|---|---|
| identity | Verified target: zebrafish gtpbp3 encodes mitochondrial GTP-binding protein 3 / tRNA taurine modification enzyme GTPBP3, a conserved TrmE-type GTPase with a mitochondrial targeting sequence and a TrmE-like G domain; this matches UniProt Q501Z5 and supports annotation as the zebrafish ortholog of mammalian mitochondrial GTPBP3 rather than another similarly named GTP-binding protein. Zhang et al. 2023 (Genes, Feb 2023) DOI/URL: https://doi.org/10.3390/genes14030552. | (zhang2023pathogenicityanalysisof pages 13-15, zhang2023pathogenicityanalysisof pages 1-2) |
| molecular function/reaction | Primary function: mitochondrial tRNA wobble-uridine modification. Cross-species evidence indicates GTPBP3 acts with MTO1 to catalyze formation of τm5U / τm5(s2)U at position U34 of selected mitochondrial tRNAs, thereby supporting accurate mitochondrial translation. GTP hydrolysis by the TrmE-type G domain is functionally important for this reaction. Zhang et al. 2023 (Genes, Feb 2023) https://doi.org/10.3390/genes14030552; Magistrati et al. 2023 (Int J Mol Sci, Jan 2023) https://doi.org/10.3390/ijms24032178. | (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12) |
| substrates/cofactors | Reported reaction inputs for the GTPBP3–MTO1 system include taurine and 5,10-methylene-THF (5,10-CH2-THF) as substrates, with GTP, K+, and FAD as required cofactors; under taurine starvation, the complex may use glycine to generate cmnm5U instead of τm5U. Upstream one-carbon units are supplied by SHMT2 or the glycine-cleavage pathway. Zhang et al. 2023 https://doi.org/10.3390/genes14030552; Magistrati et al. 2023 https://doi.org/10.3390/ijms24032178. | (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12) |
| partners/complex | GTPBP3 forms a functional complex with MTO1; Zhang et al. describe a heterologous tetrameric complex in which the GTPBP3 N-terminus mediates dimerization and the central helix contacts MTO1. Related taurine-dependent mt-tRNA modification pathways also involve TRMU/MTU1 for 2-thiolation downstream/parallel to τm5U biogenesis. Zhang et al. 2023 https://doi.org/10.3390/genes14030552; Magistrati et al. 2023 https://doi.org/10.3390/ijms24032178. | (zhang2023pathogenicityanalysisof pages 1-2, magistrati2023modopathiescausedby pages 11-12) |
| localization | Subcellular localization: mitochondrion. Evidence includes annotation as a mitochondrial tRNA-modifying enzyme, presence of a mitochondrial targeting signal, and disease/mechanistic literature consistently placing GTPBP3 in the mitochondrial tRNA modification machinery. 2024 Chinese review URL: https://doi.org/10.12125/j.chj.202212029; Zhang et al. 2023 https://doi.org/10.3390/genes14030552. | (杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5, zhang2023pathogenicityanalysisof pages 13-15, zhang2023pathogenicityanalysisof pages 1-2) |
| zebrafish LOF phenotype | Danio rerio loss-of-function evidence is limited but consistent: cited zebrafish studies report that deletion/defective expression of gtpbp3 causes hypertrophic cardiomyopathy with aberrant mitochondrial tRNA metabolism, altered mitochondrial function, and developmental defects. Secondary cross-reference from zebrafish Mto1 work notes similar mt-tRNA instability signatures and reports increased tRNA aminoacylation efficiencies in gtpbp3KO zebrafish. Detailed direct zebrafish biochemical readouts are sparsely available in the retrieved texts, so mechanistic annotation relies partly on orthology and the MTO1/GTPBP3 pathway. | (zhang2023pathogenicityanalysisof pages 15-15, zhang2021ablationofmto1 pages 11-12, 杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5) |
| human disease links/2023-2024 stats | Human ortholog evidence strongly supports function. Biallelic GTPBP3 variants cause COXPD23 with lactic acidosis/hyperlactatemia, hypertrophic cardiomyopathy, seizures, developmental delay, and encephalopathy. Zhang et al. 2023 curated 18 patients, average onset 1.7 years (reported 3 months for a homozygote); patient variants showed 48.6% LOF vs 8.9% in gnomAD (p < 0.0001), 31% frameshift, and severe cases were 71.4% homozygous vs 18.1% compound heterozygous. Xie et al. 2024 identified 13 variants in 9 Chinese pedigrees, including 8 novel variants; features included developmental delay, seizures, hypotonia, exercise intolerance, hypertrophic cardiomyopathy, plus newly noted strabismus and heart valve findings; example quantitative values included lactate 16 mM and 8.58 mM, EF 38%, NT-proBNP 894 pg/ml. The 2024 Chinese review also cites a pediatric case presenting at 3 y 5 m with LVEF 27% and lactate 3.2 mmol/L. URLs: Zhang 2023 https://doi.org/10.3390/genes14030552; Xie 2024 https://doi.org/10.1186/s13023-024-03469-3; Chinese review 2024 https://doi.org/10.12125/j.chj.202212029. | (zhang2023pathogenicityanalysisof pages 1-2, xie2024expandingthephenotypic pages 1-2, xie2024expandingthephenotypic pages 3-4, 杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5) |
Table: This table summarizes the key functional annotation points for zebrafish gtpbp3 (UniProt Q501Z5), separating direct zebrafish evidence from cross-species inference. It is useful for identifying what is strongly supported experimentally versus what is inferred from the conserved mitochondrial GTPBP3-MTO1 tRNA modification pathway.
References
(zhang2023pathogenicityanalysisof pages 13-15): Qin Zhang, Qianqian Ouyang, Jingjing Xiang, Hong Li, Haitao Lv, and Yu An. Pathogenicity analysis of a novel variant in gtpbp3 causing mitochondrial disease and systematic literature review. Genes, 14:552, Feb 2023. URL: https://doi.org/10.3390/genes14030552, doi:10.3390/genes14030552. This article has 10 citations.
(zhang2023pathogenicityanalysisof pages 1-2): Qin Zhang, Qianqian Ouyang, Jingjing Xiang, Hong Li, Haitao Lv, and Yu An. Pathogenicity analysis of a novel variant in gtpbp3 causing mitochondrial disease and systematic literature review. Genes, 14:552, Feb 2023. URL: https://doi.org/10.3390/genes14030552, doi:10.3390/genes14030552. This article has 10 citations.
(magistrati2023modopathiescausedby pages 11-12): Martina Magistrati, Alexandru Ionut Gilea, Camilla Ceccatelli Berti, Enrico Baruffini, and Cristina Dallabona. Modopathies caused by mutations in genes encoding for mitochondrial rna modifying enzymes: molecular mechanisms and yeast disease models. International Journal of Molecular Sciences, 24:2178, Jan 2023. URL: https://doi.org/10.3390/ijms24032178, doi:10.3390/ijms24032178. This article has 14 citations.
(xie2024expandingthephenotypic pages 1-2): Yaojun Xie, Keyi Li, Li Yang, Xiaofei Zeng, Zhehui Chen, Xue Ma, Luyi Zhang, Yuwei Zhou, Liqin Jin, Yanling Yang, and Xiaoting Lou. Expanding the phenotypic and genetic spectrum of gtpbp3 deficiency: findings from nine chinese pedigrees. Orphanet Journal of Rare Diseases, Dec 2024. URL: https://doi.org/10.1186/s13023-024-03469-3, doi:10.1186/s13023-024-03469-3. This article has 2 citations and is from a peer-reviewed journal.
(zhang2021ablationofmto1 pages 11-12): Qinghai Zhang, Xiao He, Shihao Yao, Tianxiang Lin, Luwen Zhang, Danni Chen, Chao Chen, Qingxian Yang, Feng Li, Yi-Min Zhu, and Min-Xin Guan. Ablation of mto1 in zebrafish exhibited hypertrophic cardiomyopathy manifested by mitochondrion rna maturation deficiency. Nucleic Acids Research, 49:4689-4704, Apr 2021. URL: https://doi.org/10.1093/nar/gkab228, doi:10.1093/nar/gkab228. This article has 28 citations and is from a highest quality peer-reviewed journal.
(杨世伟2024gtpbp3基因突变致线粒体功能障碍与肥厚型心肌病的研究进展 pages 4-5): 吉照明， 杨世伟. Gtpbp3 基因突变致线粒体功能障碍与肥厚型心肌病的研究进展. Unknown journal, 2024. URL: https://doi.org/10.12125/j.chj.202212029, doi:10.12125/j.chj.202212029.
(zhang2023pathogenicityanalysisof pages 15-15): Qin Zhang, Qianqian Ouyang, Jingjing Xiang, Hong Li, Haitao Lv, and Yu An. Pathogenicity analysis of a novel variant in gtpbp3 causing mitochondrial disease and systematic literature review. Genes, 14:552, Feb 2023. URL: https://doi.org/10.3390/genes14030552, doi:10.3390/genes14030552. This article has 10 citations.
(xie2024expandingthephenotypic pages 3-4): Yaojun Xie, Keyi Li, Li Yang, Xiaofei Zeng, Zhehui Chen, Xue Ma, Luyi Zhang, Yuwei Zhou, Liqin Jin, Yanling Yang, and Xiaoting Lou. Expanding the phenotypic and genetic spectrum of gtpbp3 deficiency: findings from nine chinese pedigrees. Orphanet Journal of Rare Diseases, Dec 2024. URL: https://doi.org/10.1186/s13023-024-03469-3, doi:10.1186/s13023-024-03469-3. This article has 2 citations and is from a peer-reviewed journal.